NCT03220048View on ClinicalTrials.gov

Study Examining PrEP-001 in Healthy Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

September 16, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Influenza A H3N2

Interventions

DRUG

PrEP-001

OTHER

Placebo Comparator

Trial Locations (1)

E1 2AX

hVIVO Services Ltd, QMB Bioenterprise building, London

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Prep Biopharm Limited

INDUSTRY

lead

Hvivo

INDUSTRY

NCT03220048 - Study Examining PrEP-001 in Healthy Subjects | Biotech Hunter | Biotech Hunter